Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 3.8M | $3.6M | 35% | Jun 2024 |
|
| Rock Springs Capital Management | 3.0M | $2.8M | 108% | Jun 2024 |
|
| RiverVest Venture Management | 1.4M | $1.1B | 0% | Sep 2024 |
|
| Morgan Stanley | 1.1M | $1.1M | 401% | Jun 2024 |
|
| Vanguard Group | 903k | $855k | 0% | Jun 2024 |
|
| Geode Capital Management | 338k | $266k | 85% | Sep 2024 |
|
| Balyasny Asset Management | 273k | $258k | -20% | Jun 2024 |
|
| Renaissance Technologies | 266k | $210k | -10% | Sep 2024 |
|
| BlackRock | 76k | $60k | 100% | Sep 2024 |
|
| Bridgeway Capital Management | 71k | $67k | 0% | Jun 2024 |
|
| BlackRock | 66k | $63k | 46% | Jun 2024 |
|
| State Street Corporation | 43k | $41k | 177% | Jun 2024 |
|
| SevenBridge Financial | 41k | $45k | 0% | Sep 2024 |
|
| Northern Trust | 39k | $31k | 120% | Sep 2024 |
|
| Raymond James & Associates | 39k | $31k | 0% | Sep 2024 |
|
| Engineers Gate Manager | 33k | $26k | 100% | Sep 2024 |
|
| Mariner Wealth Advisors | 25k | $20k | 100% | Sep 2024 |
|
| Honkamp Krueger Financial Services | 25k | $24k | 100% | Jun 2024 |
|
| Two Sigma Securities | 13k | $13k | 100% | Jun 2024 |
|
| Dunhill Financial | 10k | $8.1k | 0% | Sep 2024 |
|
| Pinnacle Financial Group, LLC / IL | 10k | $7.9k | 0% | Sep 2024 |
|
| Tower Research Capital | 4.2k | $4.0k | -62% | Jun 2024 |
|
| Key FInancial | 830.00 | $654.040000 | 0% | Sep 2024 |
|
| Private Wealth Management Group | 310.00 | $244.993000 | 100% | Sep 2024 |
|
| Bank of America Corporation | 266.00 | $208.996200 | -62% | Sep 2024 |
|
| Jpmorgan Chase & Co | 75.00 | $59.002500 | 27% | Sep 2024 |
|
| Qube Research & Technologies | 4.00 | $4.000000 | 0% | Jun 2024 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Atlas Venture Life Science Advisors | Mar 2024 | 993k | $1.1M |
| XTX Topco | Jun 2024 | 33k | $32k |
| PFG Investments | Mar 2024 | 30k | $32k |
| Millennium Management | Jun 2024 | 12k | $12k |
| Charles Schwab Investment Management | Jun 2024 | 12k | $11k |
| Royal Bank of Canada | Jun 2024 | 366.00 | $0 |